Viewing Study NCT06484920


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-01-09 @ 10:58 PM
Study NCT ID: NCT06484920
Status: RECRUITING
Last Update Posted: 2025-02-03
First Post: 2024-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Sponsor: Rita Assi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module